Liability Risk and Insurance
Aventis epilepsy drug targeted
Vigabatrin (trade name Sabril) is likely to lead to action against manufacturer Aventis led by Plymouth solicitors, Wolferstans,
acting for 30 plaintiffs. It is alleged to have damaged the vision of patients treated for epilepsy, some to the extent of
blindness.